2003
DOI: 10.1053/meta.2003.50027
|View full text |Cite
|
Sign up to set email alerts
|

Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…Adiponectin regulates glucose and fatty acid oxidation [27], chronic elevation of IL-6 promotes hepatic insulin resistance [28] while acute elevation of IL-6 promotes the supply of glucose and fat to skeletal muscle [29]. IL-8 is correlated with insulin resistance in obesity and metabolic syndrome [30,31] while PAI-1 is associated increased visceral fat mass [32] and insulin resistance in lean individuals [33]. Lipocalin-2 is associated with increased total energy expenditure and increased fat oxidation [34], and TNFα induces lipolysis [27].…”
Section: Discussionmentioning
confidence: 99%
“…Adiponectin regulates glucose and fatty acid oxidation [27], chronic elevation of IL-6 promotes hepatic insulin resistance [28] while acute elevation of IL-6 promotes the supply of glucose and fat to skeletal muscle [29]. IL-8 is correlated with insulin resistance in obesity and metabolic syndrome [30,31] while PAI-1 is associated increased visceral fat mass [32] and insulin resistance in lean individuals [33]. Lipocalin-2 is associated with increased total energy expenditure and increased fat oxidation [34], and TNFα induces lipolysis [27].…”
Section: Discussionmentioning
confidence: 99%
“…PAI-1 concentrations are directly influenced by insulin (44), even in situations of insulin resistance (45), a fact that has been explained in terms of abdominal fat, via a higher concentration of cytokines in subjects with central obesity (41). Nevertheless, the association of PAI-1 and insulin resistance has also been found in nonobese cohorts (46). These apparently contradictory findings may be partially explained by the identification of a regulatory element (AP-1 response element) in the PAI-1 promoter.…”
Section: Discussionmentioning
confidence: 99%
“…Increased concentrations of interleukin 6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) have been associated with an increased risk of T2DM [3,4]. Elevated plasminogen activator inhibitor type 1 (PAI-1) has also been found to be a predictor of the development of T2DM [5,6,7,8]. …”
Section: Introductionmentioning
confidence: 99%